前收市價 | 1.8800 |
開市 | 1.8900 |
買盤 | 1.8400 x 600 |
賣出價 | 1.8700 x 300 |
今日波幅 | 1.8400 - 1.9400 |
52 週波幅 | 0.9700 - 2.9100 |
成交量 | |
平均成交量 | 1,619,421 |
市值 | 192.922M |
Beta 值 (5 年,每月) | 1.10 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.8300 |
業績公佈日 | 2024年7月11日 - 2024年7月15日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 無 |
As the cannabis market continues to expand globally, savvy investors are looking for top cannabis stocks to buy. The global legal cannabis market is projected to reach $58 billion by 2028, driven primarily by adult-use sales in the U.S., according to BDSA. Despite the dominance of the U.S. and Canada in the market, international sales of cannabis products are forecasted to grow significantly at a compounded annual growth rate (CAGR) of 24%. This growth is also expected to be supported by governm
Here is how OrganiGram (OGI) and ResMed (RMD) have performed compared to their sector so far this year.
OrganiGram (OGI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.